Biostar Pharmaceuticals

About:

Biostar Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of over-the-counter (OTC) and prescription

Website: http://www.biostarpharmaceuticals.com

Description:

Biostar Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People’s Republic of China. Its principal product includes the Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for the treatment of chronic hepatitis B. The company’s products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat pain, headache, and fever; and Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for the treatment of pain and other symptoms associated with menstruation. Its prescription pharmaceutical products include Danshen granule for the treatment of coronary heart disease, myocarditis, and angina pectoris; and Taohuasan pediatric medicine for the treatment of bronchial congestion and coughs in children. In addition, the company manufactures hernia belt, a medical device used for the relief of hernia. Further, it provides nutrient and OTC products, which comprise Tangning capsule for the treatment of diabetes; Yizi capsule for fertility; Shengjing capsule for kidney; and Aoxing ointment to treat psoriasis, vitiligo, and various dermatitis. Biostar Pharmaceuticals, Inc. sells its products through 25 distributors and a network of approximately 400 dedicated sales people in approximately 25 provinces. The company is headquartered in Xianyang, the People’s Republic of China.